PP 7.2 – 00006 Acceptability of Home-Based Blood Collection Device for Viral Load Testing in HIV Cure Trials with Analytical Treatment Interruptions

Autor: K. Dubé, H. Agarwal, W.B. Carter, L. Dee, J. Taylor, C. Roebuck, B. Peterson, H. Patel, S. Ndukwe, K.M. Lynn, L. Lalley-Chareczko, E. Hiserodt, S. Kim, D. Rosenbloom, B.R. Evans, M. Anderson, D.J. Hazuda, K. Bateman, B.J. Howell, L. Azzoni, K. Mounzer, P. Tebas, L.J. Montaner

Publikováno v: Journal of Virus Eradication, Vol 8, Iss , Pp 100264- (2022)

Externí odkaz: https://doaj.org/article/ed461a5b5bb64e2eaa9f945208e0b98e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions

Autor: Dubé K; UNC Gillings School of Global Public Health, Chapel Hill, NC, USA., Agarwal H; UNC Gillings School of Global Public Health, Chapel Hill, NC, USA., Carter WB; BEAT-HIV Delaney Collaboratory Community Advisory Board (CAB), Philadelphia, PA, USA., Dee L; AIDS Treatment Activists Coalition (ATAC), Nationwide, Baltimore, MD, USA.; AIDS Action Baltimore, Baltimore, MD, USA.; Delaney AIDS Research Enterprise (DARE) CAB, San Francisco, CA, USA., Taylor J; AIDS Treatment Activists Coalition (ATAC), Nationwide, Baltimore, MD, USA.; Delaney AIDS Research Enterprise (DARE) CAB, San Francisco, CA, USA.; RID-HIV Collaboratory CAB, San Diego, CA, USA.; HIV + Aging Research Project - Palm Springs (HARP-PS), Palm Springs, CA, USA., Roebuck C; Department of Science and Technology Studies, Cornell University, Ithaca, NY, USA., Peterson B; Wistar Institute and BEAT-HIV Delaney Collaboratory, Philadelphia, PA, USA., Patel H; UNC Gillings School of Global Public Health, Chapel Hill, NC, USA., Ndukwe S; UNC Gillings School of Global Public Health, Chapel Hill, NC, USA., Lynn KM; Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Lalley-Chareczko L; Philadelphia FIGHT Community Health Centers, Philadelphia, PA, USA., Hiserodt E; Philadelphia FIGHT Community Health Centers, Philadelphia, PA, USA., Kim S; Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Rosenbloom D; Merck & Co, Inc., Kenilworth, NJ, USA., Evans BR; Merck & Co, Inc., Kenilworth, NJ, USA., Anderson M; Merck & Co, Inc., Kenilworth, NJ, USA., Hazuda DJ; Merck & Co, Inc., Kenilworth, NJ, USA., Bateman K; Merck & Co, Inc., Kenilworth, NJ, USA., Howell BJ; Merck & Co, Inc., Kenilworth, NJ, USA., Azzoni L; Wistar Institute and BEAT-HIV Delaney Collaboratory, Philadelphia, PA, USA., Mounzer K; Philadelphia FIGHT Community Health Centers, Philadelphia, PA, USA., Tebas P; Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Montaner LJ; Wistar Institute and BEAT-HIV Delaney Collaboratory, Philadelphia, PA, USA.

Publikováno v: HIV research & clinical practice [HIV Res Clin Pract] 2022 Aug 02; Vol. 23 (1), pp. 76-90.